Report Code: A13351 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Dysentery is a type disease related to gastroenteritis that results in bloody diarrhea. Fever, abdominal pain, and feeling of incomplete defections are different types of symptoms occur during dysentery. This disease is generally caused due to the bacterial infection named as Shigella and also known as Shigellosis. Moreover, other causes include certain chemicals, other bacteria, protozoa, and parasitic worms. Dysentery can be managed by maintaining fluid levels in the body by using oral rehydration solution therapy. Anti-amoebicidal drugs, anti-parasitic, and antibiotics are administered during the treatment of dysentery.
COVID-19 Impact Analysis            Â
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the dysentery drugs market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In 2020, huvepharma announced approval of FDA for launch of product Vetmulin. It is a liquid antibiotic which can be used in treatment of swine dysentery.
In 2019, Fresenius Kabi announced launch of Ertapenem for Injection in a 1 gram vial. This drug used in treatment of abdominal infections, urinary tract infections and dysentery conditions.
Key Benefits of the Report
Questions Answered in the Dysentery Drugs Market Report                      Â
Dysentery Drugs Market Report Highlights
Aspects | Details |
---|---|
By Drug Type |
|
By Drug Class |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Dr. Reddys Laboratories, Sun Pharmaceutical Limited, Cipla Limited, Teva Pharmaceuticals, Glenmark Pharmaceuticals, Mylan Pharmaceutical Industries Ltd., Proctor & Gamble Pharmaceuticals, GlaxoSmithKline Plc., Aurobindo Pharma, Lupin Pharmaceuticals |
Loading Table Of Content...
Start reading.
This Report and over 71,233+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time for readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers